scPharmaceuticals Obtains $45,600,000 Series B Financing Round

  • Feed Type
  • Date
    1/5/2017
  • Company Name
    scPharmaceuticals
  • Mailing Address
    131 Hartwell Avenue Lexington, MA 02421 USA
  • Company Description
    scPharmaceticals is creating innovative and important new therapeutic options by administering drugs subcutaneously using a convenient two component delivery system suitable for patient self-administration.
  • Website
    http://www.scpharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $45,600,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    This Series B investment will support the development of the operational and commercial infrastructure to bring Furoscix™ and the sc2Wear™ Infusor to market in the United States.
  • M&A Terms
  • Venture Investor
    OrbiMed
  • Venture Investor
    5AM Ventures
  • Venture Investor
    Lundbeckfond Ventures

Trending on Xconomy